Investors
 

NASDAQ: TTPH

$ 4.23

0.02 (0.47%)

Day High: 4.42
Day Low:  4.10
Volume:    671,500

4:00 PM ET
Feb 12, 2016



Delayed at least 20 min., by eSignal.


Stock price graph

     

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tetraphase Pharmaceuticals's financial performance into perspective.

View all »   RSSRecent Releases

Jan 19, 2016
Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial for TP-271

Dec 3, 2015
Tetraphase Pharmaceuticals to Present at Oppenheimer 26th Annual Healthcare Conference